# Treatment of Meniere's Disease With Migraine Medications

> **NCT05582837** · PHASE4 · RECRUITING · sponsor: **University of California, Irvine** · enrollment: 40 (estimated)

## Conditions studied

- Ménière

## Interventions

- **DRUG:** nortriptyline + topiramate

## Key facts

- **NCT ID:** NCT05582837
- **Lead sponsor:** University of California, Irvine
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-08-01
- **Primary completion:** 2027-12-30
- **Final completion:** 2027-12-30
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05582837

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05582837, "Treatment of Meniere's Disease With Migraine Medications". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05582837. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*